Edge Wealth Management LLC Revance Therapeutics, Inc. Transaction History

Edge Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$12.36 - $20.31 $51,603 - $84,794	-4,175 Closed	0 $0
Q3 2020 Oct 21, 2020	SELL	$23.23 - $34.3 $13,357 - $19,722	-575 Reduced 12.11%	4,175 $105,000
Q4 2019 Jan 29, 2020	BUY	$11.66 - $20.15 $17,490 - $30,224	1,500 Added 46.15%	4,750 $77,000
Q1 2019 Apr 11, 2019	BUY	$15.4 - $20.39 $42,350 - $56,072	2,750 Added 550.0%	3,250 $51,000
Q1 2018 Apr 05, 2018	BUY	$29.15 - $37.4 $14,575 - $18,700	500 New	500 $15,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.